Cardiopulmonary bypass system sales will expand through 2036, with conventional cardiopulmonary bypass systems holding a 71.2% share in 2026. The market was valued at USD 210.10 million in 2025 and is expected to reach USD 284.68 million by 2036, creating an incremental opportunity of USD 68.69 million between 2026 and 2036.